Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-07
2010-10-19
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S543000, C548S550000
Reexamination Certificate
active
07816395
ABSTRACT:
The present invention relates to a compound represented by the following formula:or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.
REFERENCES:
patent: 2008/0194536 (2008-08-01), Jones et al.
patent: WO-92/22527 (1992-12-01), None
patent: WO 2005/085185 (2005-09-01), None
patent: WO-2006/113552 (2006-10-01), None
patent: WO2007/065093 (2007-06-01), None
patent: WO-2007/065093 (2007-06-01), None
patent: WO2008/077089 (2008-06-01), None
Hoang Tram H.
Washburn David G.
Brink Robert H.
GlaxoSmithKline LLC
Shameem Golam M
LandOfFree
Pyrrolidinone anilines as progesterone receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidinone anilines as progesterone receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidinone anilines as progesterone receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168220